Clinical Trial Update: Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov listing for a Phase 2/3 trial comparing dabigatran to enoxaparin in patients with portal vein thrombosis and cirrhosis, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Vein Thrombosis

Drugs mentioned

• Lovenox (enoxaparin)
• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Portal Vein Thrombosis, Liver Cirrhosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING